Programmed Cell Death News and Research

RSS
Review highlights unique characteristics and mechanisms of ferroptosis

Review highlights unique characteristics and mechanisms of ferroptosis

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Duke researchers discover drug to restore aged livers

Duke researchers discover drug to restore aged livers

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Canagliflozin: A breakthrough in senolytic treatment for aging-related diseases

Canagliflozin: A breakthrough in senolytic treatment for aging-related diseases

Review highlights the rapidly evolving landscape of hepatocellular carcinoma treatment

Review highlights the rapidly evolving landscape of hepatocellular carcinoma treatment

Wayne State University researcher receives NIH grant to tackle diabetic eye infections

Wayne State University researcher receives NIH grant to tackle diabetic eye infections

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

Study reveals key protein's role in balancing immune response to viral infections

Study reveals key protein's role in balancing immune response to viral infections

U-M study reveals potential pathway to reverse lung fibrosis

U-M study reveals potential pathway to reverse lung fibrosis

NUS study reveals key mechanisms behind drug resistance in relapsed acute myeloid leukemia

NUS study reveals key mechanisms behind drug resistance in relapsed acute myeloid leukemia

Study reveals key mechanism of PD-1 function

Study reveals key mechanism of PD-1 function

Gut bacteria strains could be the key to predicting cancer treatment success

Gut bacteria strains could be the key to predicting cancer treatment success

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Hydrogel with built-in antibiofilm and antioxidative functions promotes faster healing of infected chronic wounds

Hydrogel with built-in antibiofilm and antioxidative functions promotes faster healing of infected chronic wounds

Study sheds light on 7-DHC's potential to induce cell death-resistant state in tumors

Study sheds light on 7-DHC's potential to induce cell death-resistant state in tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.